Raysearch Laboratories
117 SEK +2.45%1 investor is following this company
RaySearch Laboratories is a biotechnology company. The company specializes in the development of software solutions for the healthcare industry. An area where the company's products are used is in the treatment of cancer and other serious diseases. The company's products include products for dose planning and information systems. Various features include machine learning, computational speed, automated planning, virtual simulation, adaptive therapy, and digital workflows. The products are used by several clinics around the global market.
Read moreRevenue
1.02B
EBIT %
11.24 %
P/E
49.16
Dividend yield-%
1.71 %
Target price
-
Recommendation
-
Updated
-
NASDAQ Stockholm
RAY B
Daily low / high price
114.4 / 117
SEK
Market cap
4.01B SEK
Turnover
2.51M SEK
Volume
22K
Financial calendar
Interim report
2024-05-17
General meeting
2024-05-22
Annual dividend
2024-05-23
Bonus dividend
2024-05-23
Interim report
2024-08-16
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Johan Löf | 16.5 % | 53.0 % |
Northern Trust Company, London Branch | 8.3 % | 2.8 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
RaySearch Laboratories: RaySearch publicerar årsredovisning för 2023
RaySearch Laboratories: Raigmore Hospital in Scotland selects RayCare
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools